Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB BIOSCIENCES, Inc.
Age
16–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has a diagnosis of uncontrolled epilepsy with primary generalized tonic-clonic (PGTC) seizures and idiopathic generalized epilepsy. Diagnosis should have been established by an electroencephalogram (EEG) with generalized spike-wave discharges within 5 years of the screening visit
Subject has ≥1 PGTC seizure within the 12 weeks prior to the screening visit
Subject has a stable dose regimen of 1 to 3 marketed antiepileptic drug(s) (AEDs) with or without additional concurrent stable Vagus Nerve Stimulation (VNS). The VNS must have been in place for at least 6 months prior to study entry with constant settings for at least 28 days prior to the screening visit and during the Baseline Phase. Benzodiazepines will be counted as an AED
You may not be if
Subject has a history of partial-onset seizures or EEG findings consistent with partial onset seizures
Subject has a history of status epilepticus within the 5-year Period prior to Visit 1
Subject has a current or previous diagnosis of pseudoseizures, conversion disorders, or other non-epileptic ictal events
Subject has any medical or psychiatric condition
Subject has any history of alcohol or drug abuse
Subject is currently taking felbamate
Subject has ever taken vigabatrin and has no visual fields examination report available or if results of the examination are abnormal
